T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T cells engrafted with a UniCAR 28/z outperform UniCAR BB/z-transduced T cells in the face of regulatory T cell-mediated immunosuppression
Authors
Keywords
-
Journal
OncoImmunology
Volume 8, Issue 9, Pages e1621676
Publisher
Informa UK Limited
Online
2019-06-07
DOI
10.1080/2162402x.2019.1621676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulatory T cells: a potential target in cancer immunotherapy
- (2018) Kohei Shitara et al. Annals of the New York Academy of Sciences
- Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology
- (2018) Stefanie Koristka et al. JOURNAL OF AUTOIMMUNITY
- Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy
- (2018) Yanyu Pang et al. Molecular Cancer
- CD28-ζ CAR T cells resist TGF-β repression through IL-2 signaling which can be mimicked by IL-7 and an engineered IL-7/IL-2Rβ autocrine loop
- (2018) Viktória Golumba-Nagy et al. MOLECULAR THERAPY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical and Biologic Correlates of Neurotoxicity Associated with CAR T Cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia (B-ALL)
- (2018) Bianca D. Santomasso et al. Cancer Discovery
- From mono- to bivalent: improving theranostic properties of target modules for redirection of UniCAR T cells against EGFR-expressing tumor cells in vitro and in vivo
- (2018) Susann Albert et al. Oncotarget
- Strategies to Address Chimeric Antigen Receptor Tonic Signaling
- (2018) Adam Ajina et al. MOLECULAR CANCER THERAPEUTICS
- Development of a novel target module redirecting UniCAR T cells to Sialyl Tn-expressing tumor cells
- (2018) L. R. Loureiro et al. Blood Cancer Journal
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Chimeric antigen receptor T-cell therapies for lymphoma
- (2017) Jennifer N. Brudno et al. Nature Reviews Clinical Oncology
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- Retargeting of UniCAR T cells with an in vivo synthesized target module directed against CD19 positive tumor cells
- (2017) Dominik Bachmann et al. Oncotarget
- Development of novel target modules for retargeting of UniCAR T cells to GD2 positive tumor cells
- (2017) Nicola Mitwasi et al. Oncotarget
- Retargeting of T lymphocytes to PSCA- or PSMA positive prostate cancer cells using the novel modular chimeric antigen receptor platform technology “UniCAR”
- (2017) Anja Feldmann et al. Oncotarget
- A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform
- (2017) Susann Albert et al. OncoImmunology
- Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview
- (2016) C. H. J. Lamers et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura
- (2016) E. E. Page et al. BLOOD
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Hurdles of CAR-T cell-based cancer immunotherapy directed against solid tumors
- (2016) Bing-Lan Zhang et al. Science China-Life Sciences
- Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
- (2016) Kaichao Feng et al. Science China-Life Sciences
- Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts
- (2016) M Cartellieri et al. Blood Cancer Journal
- Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
- (2015) Zeguo Zhao et al. CANCER CELL
- Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma
- (2015) Elias J. Sayour et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
- (2015) M. J. Frigault et al. Cancer Immunology Research
- A Novel Ex Vivo Isolation and Expansion Procedure for Chimeric Antigen Receptor Engrafted Human T Cells
- (2014) Marc Cartellieri et al. PLoS One
- Redirection of CD4+and CD8+T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+prostate tumor cells
- (2014) Claudia Arndt et al. PROSTATE
- Cytotoxic response of human regulatory T cells upon T-cell receptor-mediated activation: a matter of purity
- (2014) S Koristka et al. Blood Cancer Journal
- Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B
- (2013) Stefanie Koristka et al. JOURNAL OF AUTOIMMUNITY
- Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis
- (2013) Hong Nie et al. NATURE MEDICINE
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer
- (2012) Anna Flammiger et al. EUROPEAN JOURNAL OF CANCER
- Kinetics and Activation Requirements of Contact-Dependent Immune Suppression by Human Regulatory T Cells
- (2012) M. Hagness et al. JOURNAL OF IMMUNOLOGY
- Relative Resistance of Human CD4+ Memory T Cells to Suppression by CD4+CD25+ Regulatory T Cells
- (2011) B. Afzali et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Functional human regulatory T cells fail to control autoimmune inflammation due to PKB/c-akt hyperactivation in effector cells
- (2011) E. J. Wehrens et al. BLOOD
- Retargeting of Human Regulatory T Cells by Single-Chain Bispecific Antibodies
- (2011) S. Koristka et al. JOURNAL OF IMMUNOLOGY
- CD28 Costimulation Impairs the Efficacy of a Redirected T-cell Antitumor Attack in the Presence of Regulatory T cells Which Can Be Overcome by Preventing Lck Activation
- (2011) David M Kofler et al. MOLECULAR THERAPY
- A Novel Modular Antigen Delivery System for Immuno Targeting of Human 6-sulfo LacNAc-Positive Blood Dendritic Cells (SlanDCs)
- (2011) Claudia C. Bippes et al. PLoS One
- Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
- (2010) Marc Cartellieri et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Retargeting of T cells to prostate stem cell antigen expressing tumor cells: Comparison of different antibody formats
- (2010) Anja Feldmann et al. PROSTATE
- IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
- (2009) M. B. Ahmed et al. JOURNAL OF IMMUNOLOGY
- Regulatory T-Cell Suppression of CD8+ T-Cell-Mediated Graft-Versus-Host Reaction Requires Their Presence During Priming
- (2009) Xiao-Nong Wang et al. TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now